A Long-term Safety Study of Once-daily Travatan

Verified by: Alcon Research, April 2010
First Received: January 3, 2003 | Last Updated: October 2, 2011 | Phase: Phase 3 | Start Date: January 2006
Overall Status: Completed | Estimated Enrollment: 502
  • …
  • Tell a FriendPrint

Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension...

Brief Summary

Official Title: “A Long-term Safety Study of Once-daily TRAVATAN”

Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension.

  • Study Type: Interventional
  • Study Design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
  • Study Primary Completion Date: March 2009

Intervention(s) in this Clinical Trial

  • Drug: Travatan
    • Travoprost (0.004%) 1 drop each eye once daily

Arms, Groups and Cohorts in this Clinical Trial

  • Experimental: Travatan
    • Travoprost (0.004%)

Outcome Measures for this Clinical Trial

Primary Measures

  • Mean Intraocular Pressure
    • Time Frame: At 5 years.
      Safety Issue?: Yes

Criteria for Participation in this Clinical Trial

  • Adult patients of any race and either sex with chronic angle-closure glaucoma.

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: Alcon Research Industry

Additional Information

Information obtained from ClinicalTrials.gov on February 09, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00051168

Study ID Number: C-02-20

ClinicalTrials.gov Identifier: NCT00051168

Health Authority: United States: Food and Drug Administration

  • …
  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00051168